Journal of Clinical Endocrinology & Metabolism, Vol 69, 585-592, Copyright © 1989 by Endocrine Society

ARTICLES

Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function

IS Fraser, ZG Lun, JP Zhou, AC Herington, G McCarron, I Caterson, K Tan and R Markham
Department of Obstetrics and Gynecology, University of Sydney, New South Wales, Australia.

Six women with elevated circulating levels of big big PRL (BBPRL) and apparently normal ovarian function were variously studied through a menstrual cycle and menstruation, through pregnancy and suckling, and during stimulation tests with TRH and suppression with bromocriptine. No significant changes in monomeric PRL were demonstrated during the menstrual cycle, but all subjects showed a small and significant rise in BBPRL during the preovulatory phase. High PRL levels were present in day 1 menstrual plasma, but BBPRL was only present in low concentrations. All subjects (n = 5) demonstrated a rise in both PRL and BBPRL during pregnancy, with a consistent tendency for PRL to increase to a proportionately greater extent than BBPRL. One subject exhibited a rise in PRL (by 93%), but not BBPRL, 30 min after suckling. TRH caused a brisk rise in PRL (by 363 +/- 116%) but only a sluggish rise in BBPRL (by 17.5 +/- 7.4%; n = 3). Bromocriptine rapidly suppressed PRL (by 81.8 +/- 34.4%), but only slowly suppressed BBPRL (by 21.0 +/- 8.7% after 6 h; n = 3). Plasma binding studies did not demonstrate any evidence of a circulating specific PRL-binding protein. These data indicate that plasma concentrations of BBPRL may vary under the influence of a number of factors, but are much less sensitive to TRH stimulation, bromocriptine suppression, pregnancy, and suckling than PRL. The occurrence of BBPRL does not seem to be due to a specific circulating binding protein.

This article has been cited by other articles:

				L. Beltran, M. N. Fahie-Wilson, T. J. McKenna, L. Kavanagh, and T. P. Smith Serum Total Prolactin and Monomeric Prolactin Reference Intervals Determined by Precipitation with Polyethylene Glycol: Evaluation and Validation on Common ImmunoAssay Platforms Clin. Chem., October 1, 2008; 54(10): 1673 - 1681. [Abstract] [Full Text] [PDF]

				L. Kavanagh, T. J. McKenna, M. N. Fahie-Wilson, J. Gibney, and T. P. Smith Specificity and Clinical Utility of Methods for the Detection of Macroprolactin Clin. Chem., July 1, 2006; 52(7): 1366 - 1372. [Abstract] [Full Text] [PDF]

				J. Gibney, T. P. Smith, and T. J. McKenna The Impact on Clinical Practice of Routine Screening for Macroprolactin J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3927 - 3932. [Abstract] [Full Text] [PDF]

				M Garcia, M E Colombani-Vidal, C C Zylbersztein, A Testi, J Marcos, A Arturi, J Babini, and H E Scaglia Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus Lupus, August 1, 2004; 13(8): 575 - 583. [Abstract] [PDF]

				M. Fahie-Wilson In Hyperprolactinemia, Testing for Macroprolactin Is Essential Clin. Chem., September 1, 2003; 49(9): 1434 - 1436. [Full Text] [PDF]

				A. M. Suliman, T. P. Smith, J. Gibney, and T. J. McKenna Frequent Misdiagnosis and Mismanagement of Hyperprolactinemic Patients before the Introduction of Macroprolactin Screening: Application of a New Strict Laboratory Definition of Macroprolactinemia Clin. Chem., September 1, 2003; 49(9): 1504 - 1509. [Abstract] [Full Text] [PDF]

				S. Vallette-Kasic, I. Morange-Ramos, A. Selim, G. Gunz, S. Morange, A. Enjalbert, P.-M. Martin, P. Jaquet, and T. Brue Macroprolactinemia Revisited: A Study on 106 Patients J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 581 - 588. [Abstract] [Full Text] [PDF]

				F Blanco-Favela, K Chavez-Rueda, and A Leanos-Miranda Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 757 - 761. [Abstract] [PDF]

				A. Leanos-Miranda, D. Pascoe-Lira, K. A. Chavez-Rueda, and F. Blanco-Favela Persistence of Macroprolactinemia Due to Antiprolactin Autoantibody before, during, and after Pregnancy in a Woman with Systemic Lupus Erythematosus J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2619 - 2624. [Abstract] [Full Text] [PDF]

				H. Leslie, C. H. Courtney, P. M. Bell, D. R. Hadden, D. R. McCance, P. K. Ellis, B. Sheridan, and A. B. Atkinson Laboratory and Clinical Experience in 55 Patients with Macroprolactinemia Identified by a Simple Polyethylene Glycol Precipitation Method J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2743 - 2746. [Abstract] [Full Text] [PDF]

				A Leanos-Miranda, D Pascoe-Lira, K A Chavez-Rueda, and F Blanco-Favela Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia Lupus, May 1, 2001; 10(5): 340 - 345. [Abstract] [PDF]

				M. J. Diver, D. L. Ewins, R. C. Worth, S. Bowles, J. A. Ahlquist, and M. N. Fahie-Wilson An Unusual Form of Big, Big (Macro) Prolactin in a Pregnant Patient Clin. Chem., February 1, 2001; 47(2): 346 - 348. [Full Text] [PDF]

				A Leanos, D Pascoe, A Fraga, and F Blanco-Favela Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia Lupus, July 1, 1998; 7(6): 398 - 403. [Abstract] [PDF]

				J. B. Kline and C. V. Clevenger Identification and Characterization of the Prolactin-binding Protein in Human Serum and Milk J. Biol. Chem., June 29, 2001; 276(27): 24760 - 24766. [Abstract] [Full Text] [PDF]